BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18523262)

  • 21. Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M.
    Honey K; Forbush K; Jensen PE; Rudensky AY
    J Immunol; 2004 Apr; 172(7):4142-50. PubMed ID: 15034026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice.
    Nakagawa TY; Brissette WH; Lira PD; Griffiths RJ; Petrushova N; Stock J; McNeish JD; Eastman SE; Howard ED; Clarke SR; Rosloniec EF; Elliott EA; Rudensky AY
    Immunity; 1999 Feb; 10(2):207-17. PubMed ID: 10072073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis.
    Myers LK; Tang B; Rosloniec EF; Stuart JM; Chiang TM; Kang AH
    J Immunol; 1998 Oct; 161(7):3589-95. PubMed ID: 9759881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide.
    Zechel MA; Chaturvedi P; Lee-Chan EC; Rider BJ; Singh B
    J Immunol; 1996 Jun; 156(11):4232-9. PubMed ID: 8666792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parental MHC molecule haplotype expression in (SJL/J x SWR)F1 mice with acute experimental allergic encephalomyelitis induced with two different synthetic peptides of myelin proteolipid protein.
    Sobel RA; Tuohy VK; Lees MB
    J Immunol; 1991 Jan; 146(2):543-9. PubMed ID: 1702806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
    Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
    J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination with an immunodominant peptide of bovine type II collagen induces an anti-TCR response, and modulates the onset and severity of collagen-induced arthritis.
    Honda A; Ametani A; Matsumoto T; Iwaya A; Kano H; Hachimura S; Ohkawa K; Kaminogawa S; Suzuki K; Sercarz EE; Kumar V
    Int Immunol; 2004 May; 16(5):737-45. PubMed ID: 15096482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes.
    Bischof F; Wienhold W; Wirblich C; Malcherek G; Zevering O; Kruisbeek AM; Melms A
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12168-73. PubMed ID: 11593032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain.
    Fineschi B; Sakaguchi K; Appella E; Miller J
    J Immunol; 1996 Oct; 157(8):3211-5. PubMed ID: 8871612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice at multiple steps.
    Dasgupta S; Zhou Y; Jana M; Banik NL; Pahan K
    J Immunol; 2003 Apr; 170(7):3874-82. PubMed ID: 12646656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of antigen specificity, class II major histocompatibility complex restriction, and in vivo behavior of myelin basic protein-specific T cell lines and clones derived from (BALB/c x SJL/J) mice.
    Trotter J; Zamvil SS; Steinman L
    J Immunol; 1987 Sep; 139(6):1834-9. PubMed ID: 2442257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis.
    Morgan ME; Sutmuller RP; Witteveen HJ; van Duivenvoorde LM; Zanelli E; Melief CJ; Snijders A; Offringa R; de Vries RR; Toes RE
    Arthritis Rheum; 2003 May; 48(5):1452-60. PubMed ID: 12746920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minor lymphocyte stimulating (Mls) gene products in mice influence their genetic resistance or susceptibility to induction of autoimmune encephalomyelitis.
    Ben-Nun A; Soffer D
    Eur J Immunol; 1990 Jan; 20(1):195-200. PubMed ID: 1689661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single-chain class II MHC-IgG3 fusion protein inhibits autoimmune arthritis by induction of antigen-specific hyporesponsiveness.
    Zuo L; Cullen CM; DeLay ML; Thornton S; Myers LK; Rosloniec EF; Boivin GP; Hirsch R
    J Immunol; 2002 Mar; 168(5):2554-9. PubMed ID: 11859151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Streptococcus sanguis modulates type II collagen-induced arthritis in DBA/1J mice.
    Costalonga M; Hodges JS; Herzberg MC
    J Immunol; 2002 Aug; 169(4):2189-95. PubMed ID: 12165549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.
    Bevec T; Stoka V; Pungercic G; Dolenc I; Turk V
    J Exp Med; 1996 Apr; 183(4):1331-8. PubMed ID: 8666891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Torilin ameliorates type II collagen-induced arthritis in mouse model of rheumatoid arthritis.
    Endale M; Lee WM; Kwak YS; Kim NM; Kim BK; Kim SH; Cho J; Kim S; Park SC; Yun BS; Ko D; Rhee M
    Int Immunopharmacol; 2013 Jun; 16(2):232-42. PubMed ID: 23623942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
    Nandakumar KS; Bäcklund J; Vestberg M; Holmdahl R
    Arthritis Res Ther; 2004; 6(6):R544-50. PubMed ID: 15535832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic vaccination of active arthritis with a glycosylated collagen type II peptide in complex with MHC class II molecules.
    Dzhambazov B; Nandakumar KS; Kihlberg J; Fugger L; Holmdahl R; Vestberg M
    J Immunol; 2006 Feb; 176(3):1525-33. PubMed ID: 16424181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.